This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (11)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Alzheimer Disease  • Neurogenetics  • Genetic Disorders  • Alert me on articles by topic  Social Bookmarking   What's this?

Mario Zappia, MD; Ida Manna, PhD; Paolo Serra, PhD; Rita Cittadella, PhD; Virginia Andreoli, PhD; Antonella La Russa, PhD; Fernanda Annesi, PhD; Patrizia Spadafora, PhD; Nelide Romeo, PhD; Giuseppe Nicoletti, MD; Demetrio Messina, MD; Antonio Gambardella, MD; Aldo Quattrone, MD

Arch Neurol. 2004;61:341-344.

Background  The genes encoding myeloperoxidase (MPO) and ₂-macroglobulin (A2M) are involved in molecular pathways leading to -amyloid deposition. Two polymorphic sites in these genes (MPO-G/A and A2M-Ile/Val) have been associated with Alzheimer disease (AD), but conflicting findings have been reported in populations with different ethnic backgrounds.

Objectives  To study the association of MPO-G/A and A2M-Ile/Val polymorphisms with sporadic AD and to investigate the interactions among the MPO, A2M, and apolipoprotein E (APOE) gene polymorphisms in determining the risk of the development of AD.

Design  Case-control study.

Setting  Referral center for AD in Calabria, southern Italy.

Participants  One hundred forty-eight patients with sporadic AD and 158 healthy control subjects.

Results  The MPO-G and A2M-Val alleles were found more frequently in cases than in controls, as were the MPO-G/G and A2M-Val/Val genotypes. The odds ratio (OR) for the MPO-G/G genotype was 1.78 (95% confidence interval [CI], 1.13-2.80); for the A2M-Val/Val genotype, 3.81 (95% CI, 1.66-8.75). The presence of MPO-G/G and A2M-Val/Val genotypes synergistically increased the risk of AD (OR, 25.5; 95% CI, 4.65-139.75). Stratification of cases by sex, age at onset of AD, and APOE-4 status did not show significant differences in the distribution of MPO or A2M polymorphisms.

Conclusions  The MPO and A2M polymorphisms are associated with sporadic AD in southern Italy. Moreover, a genomic interaction between these polymorphisms increases the risk of the development of AD.

From the Institute of Neurology, University Magna Græcia, Catanzaro, Italy (Drs Zappia, Gambardella, and Quattrone); and the Institute of Neurological Sciences, National Research Council, Piano Lago–Cosenza, Italy (Drs Zappia, Manna, Serra, Cittadella, Andreoli, La Russa, Annesi, Spadafora, Romeo, Nicoletti, Messina, Gambardella, and Quattrone).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Aberrant Expression of Myeloperoxidase in Astrocytes Promotes Phospholipid Oxidation and Memory Deficits in a Mouse Model of Alzheimer Disease
Maki et al.
J. Biol. Chem. 2009;284:3158-3169.
ABSTRACT | FULL TEXT  

-463 G/A myeloperoxidase promoter polymorphism in giant cell arteritis
Salvarani et al.
Ann Rheum Dis 2008;67:485-488.
ABSTRACT | FULL TEXT  

Myeloperoxidase Polymorphism and Cognitive Decline in Older Adults in the Health, Aging, and Body Composition Study
Pope et al.
Am J Epidemiol 2006;163:1084-1090.
ABSTRACT | FULL TEXT